Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders

Details for Australian Patent Application No. 2002247104 (hide)

Owner Inspire Pharmaceuticals, Inc.

Inventors Peterson, Ward, M.; Yerxa, Benjamin, R.

Agent Davies Collison Cave

Pub. Number AU-B-2002247104

PCT Pub. Number WO2002/060454

Priority 09/817,017 23.03.01 US; 09/774,752 30.01.01 US

Filing date 29 January 2002

Wipo publication date 12 August 2002

Acceptance publication date 25 May 2006

International Classifications

A61K 31/7084 (2006.01) - Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide

A61K 31/70 (2006.01) - Carbohydrates

A61P 27/02 (2006.01) Drugs for disorders of the senses

C07H 19/207 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002247104

25 May 2006 Application Accepted

  Published as AU-B-2002247104

21 September 2006 Standard Patent Sealed

27 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002247105-STABILIZATION OF HYPOALLERGENIC, HYPERDIGESTIBLE PREVIOUSLY REDUCED PROTEINS

2002247103-DRAIN ASSEMBLY WITH INSTALLATION AID STOPPER GUIDE